| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |